Get the Stockscreener App
1.52
5.57%
0.09
Shuttle Pharmaceuticals Holdings Inc stock is traded at $1.52, with a volume of 209.28K.
It is up +5.57% in the last 24 hours and down -15.66% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$1.43
Open:
$1.38
24h Volume:
209.28K
Relative Volume:
0.51
Market Cap:
$2.90M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-3.3043
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
-23.75%
1M Performance:
-15.66%
6M Performance:
-61.68%
1Y Performance:
-92.90%
1-Day Range:
$1.37
$1.525
1-Week Range:
$1.29
$2.73
52-Week Range:
$1.26
$25.25
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
1.5097 | 2.75M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
125.33 | 54.92B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.46 | 50.58B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.925 | 43.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.59 | 37.25B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
472.22 | 20.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Shuttle PharmaceuticalsUtah Approves AI Prescriptions Drugs, How AI Is Saving Time, Cutting Costs and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever - marketscreener.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Utah lets AI refill meds—and how a drug discovery platform fits this shift - Stock Titan
Shuttle Pharmaceuticals Announces Board Resignation Amid Governance Transition - TipRanks
Shuttle Pharmaceuticals appoints Yuying Liang as CFO, director resigns By Investing.com - Investing.com Nigeria
Shuttle Pharmaceuticals appoints Yuying Liang as CFO, director resigns - Investing.com
Shuttle Pharmaceuticals Holdings Inc appoints Yuying Liang as CFOSEC filing - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Can Shuttle Pharmaceuticals Holdings Inc. stock deliver consistent earnings growthEarnings Performance Report & Stepwise Trade Signal Implementation - Улправда
How Shuttle Pharmaceuticals Holdings Inc. stock reacts to oil pricesMarket Activity Summary & High Conviction Trade Alerts - ulpravda.ru
Will Shuttle Pharmaceuticals Holdings Inc. stock see PE expansionDividend Hike & Low Risk Entry Point Guides - Улправда
Shuttle Pharmaceuticals Raises $2.5 Million in Private Placement - MSN
Shuttle Pharmaceuticals Holdings, Inc. Announces Chief Financial Officer Changes - marketscreener.com
Shuttle Pharmaceuticals accelerates equity payment in asset deal - MSN
What drives Shuttle Pharmaceuticals Holdings Inc stock priceDividend Stock Watch & Big Profit Small Budget - Early Times
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Shuttle Pharmaceuticals Accelerates Equity Payment in Asset Deal - TipRanks
Shuttle Pharmaceuticals Holdings Signs First Amendment to Asset Purchase Agreement With 1542770 BC - TradingView — Track All Markets
Shuttle Pharmaceuticals (SHPH) discloses 19.99% stock issuance for asset payment - Stock Titan
RSI Suggests Rebound May Be Near in Best Agrolife LimitedSector Performance Review & Daily Tips From Top Market Analysts - earlytimes.in
Shuttle Pharmaceuticals Holdings Inc Stock Analysis and ForecastSupport Zone Identification & High Return Stock Ideas - earlytimes.in
Astec LifeSciences Limited Stages Intraday Comeback Trend ChangeVolatility Adjusted Trading & Rapid Capital Appreciation - earlytimes.in
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 6.3% – Time to Sell? - Defense World
How Shuttle Pharmaceuticals Holdings Inc. stock benefits from global expansion2025 Market Outlook & Accurate Buy Signal Notifications - Улправда
Will Shuttle Pharmaceuticals Holdings Inc. stock benefit from AI adoptionPortfolio Return Summary & Reliable Price Breakout Signals - Улправда
Can Shuttle Pharmaceuticals Holdings Inc. stock deliver strong Q4 earningsTrade Volume Report & Free Long-Term Investment Growth Plans - Улправда
How Shuttle Pharmaceuticals Holdings Inc. stock reacts to job market dataWall Street Watch & High Yield Equity Trading Tips - Улправда
Aug Spikes: Will Shuttle Pharmaceuticals Holdings Inc. stock benefit from infrastructure spendingEarnings Recap Summary & Reliable Price Breakout Alerts - Улправда
Shuttle Pharmaceuticals Completes Strategic Asset Acquisition - MSN
Patterns Watch: Will Shuttle Pharmaceuticals Holdings Inc. stock benefit from infrastructure spendingPortfolio Gains Summary & AI Based Buy/Sell Signal Reports - Улправда
Is Shuttle Pharmaceuticals Holdings Inc. stock a buy on dipsBuy Signal & Low Drawdown Investment Ideas - ulpravda.ru
A activityGDP Growth & Free Safe Capital Growth Stock Tips - DonanımHaber
Trade Report: How Shuttle Pharmaceuticals Holdings Inc. stock benefits from tech adoptionJuly 2025 Review & Verified Trade Idea Suggestions - Улправда
Published on: 2025-12-19 03:09:15 - ulpravda.ru
Shuttle Pharmaceuticals’ Terminated Glioblastoma Trial: What Investors Need to Know Now - TipRanks
Shuttle Pharmaceuticals’ terminated glioblastoma trial: What investors need to know now - MSN
Shuttle Pharmaceuticals (NASDAQ: SHPH) details 625,156-share resale registration - Stock Titan
Retail Surge: How Shuttle Pharmaceuticals Holdings Inc. stock benefits from global expansionEarnings Beat & Expert Approved Trade Ideas - moha.gov.vn
Published on: 2025-12-06 06:28:12 - moha.gov.vn
Shuttle Pharmaceuticals Holdings Inc. (SHPH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Shuttle Pharmaceuticals Holdings Inc. stock gain from government policiesEarnings Summary Report & Verified High Yield Trade Plans - Newser
Why Shuttle Pharmaceuticals Holdings Inc. stock is favored by pension fundsJuly 2025 Volume & Free Technical Confirmation Trade Alerts - Newser
Shuttle Pharmaceuticals (SHPH) Stock Analysis Report | Financials & Insights - Benzinga
Shuttle Pharmaceuticals CFO Resigns, Interim CEO Steps In - The Globe and Mail
Shuttle Pharmaceuticals CFO resigns, interim CEO steps in as acting CFO By Investing.com - Investing.com UK
Shuttle Pharmaceuticals CFO resigns, interim CEO steps in as acting CFO - Investing.com
Shuttle Pharmaceuticals Holdings IncTimothy Lorber resigns as CFO of Shuttle PharmaceuticalsSEC filing - marketscreener.com
Shuttle Pharmaceuticals Announces CFO Resignation and Interim Appointment - TradingView
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):